Guckenberger, M.; Alongi, F.; Ricardi, U.; Scorsetti, M.; Balermpas, P.; Livi, L.; Lievens, Y.; Braam, P.; Jereczek- Fossa, B.A.; Stellamans, K.; Ratosa, I.; Peulen, H.; Widder, J.; Ramella, S.; Verbeke, L.; Dirix, P.; Khanfir, K.; Zilli, T.; Hemmatazad, H.; Jeene, P.; ... (2022). OC-0599 Factors associated with SBRT doses in oligometastatic disease: an EORTC/ESTRO OligoCare analysis. Radiotherapy and oncology, 170, S523-S524. Elsevier 10.1016/S0167-8140(22)02621-4
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
1-s2.0-S0167814022026214-main.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (187kB) |
Item Type: |
Conference or Workshop Item (Abstract) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology |
UniBE Contributor: |
Hemmatazad, Hossein |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0167-8140 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Basak Ginsbourger |
Date Deposited: |
20 Dec 2022 10:59 |
Last Modified: |
20 Dec 2022 18:39 |
Publisher DOI: |
10.1016/S0167-8140(22)02621-4 |
BORIS DOI: |
10.48350/176103 |
URI: |
https://boris.unibe.ch/id/eprint/176103 |
Actions (login required)
 |
Edit item |